Items with tag "diabetes"

News

ThromboGenics starts Diabetic Macular Edema trial phase II

ThromboGenics NV, an integrated biopharmaceutical company, focused on developing novel medicines for diabetic eye disease, announces the enrollment of the first patients in a Phase II, single-mask…

Read more

Novo Nordisk’s diabetes drug also lowers heart risks

Since Eli Lilly and Boehringer Ingelheim demonstrated that their diabetes pill Jardiance lowers the risk of cardiovascular complications, competitors such as Merck, Pfizer and Novo Nordisk have be…

Read more

Fingernails for easy diabetes diagnostics

If it’s up to the University of Ghent, doctors soon won’t need blood anymore to detect diabetes. A piece of fingernail can be sufficient. “Especially for developing countries, this method is a…

Read more

Insights

A microbiome solution for type 1 diabetes?

A microbiome solution for type 1 diabetes?

Few things unite us the way trying to help a sick child does. Children living with the burden of type 1 diabetes (T1D) is just such a case. The desire to help young patients has galvanized a globa…

Read more

New beta cell antigens discovered in Type 1 diabetes

New beta cell antigens discovered in Type 1 diabetes

A study published just last week has unveiled several new antigens implicated in Type 1 diabetes. In an ongoing project, researchers are working to understand the immune system failures that cause…

Read more

Imaging beta-cells for better diabetes treatment

Imaging beta-cells for better diabetes treatment

One in eleven adults around the world has diabetes, according to figures published by the International Diabetes Federation (IDF) in 2017. A research team, led by Professor Decio L. Eizirik (ULB C…

Read more

The controversy around sugar and cancer

The controversy around sugar and cancer

In a recent article published in Nature Communications (1) by a group of scientists led by Belgian professor Johan Thevelein from VIB-KU Leuven, it was revealed that sugar breakdown activates Ras …

Read more

reMYND brings in Novo Nordisk to develop diabetes therapy

reMYND brings in Novo Nordisk to develop diabetes therapy

reMYND entered into a license agreement to further develop novel treatments improving beta-cell health and insulin signalling with Novo Nordisk. The companies have entered into a license agreement…

Read more

Using bacteria to fight obesity and diabetes

Using bacteria to fight obesity and diabetes

Using the gut bacterium Akkermansia muciniphila to treat obese and diabetic patients is now one step closer to becoming a reality, thanks to the work of a group of researchers led by Patrice Cani …

Read more

Zebrafish reveal the secret origins of β-cells

Zebrafish reveal the secret origins of β-cells

How can we improve the treatment and quality of life of diabetic patients? One possible approach involves the renewal of pancreatic β-cells, which are responsible for the production of insulin. A …

Read more

Sugar may not be the only culprit causing diabetes and obesity

Sugar may not be the only culprit causing diabetes and obesity

It may no longer be sufficient to limit your intake of sugary snacks or to spend hours in the gym to avoid diabetes and obesity, as the presence of food contaminants known as persistent organic po…

Read more

Sign up to our Mailing List to receive updates
of our latest News, Events & Magazines

GSK Biowin Turnstone Flanders.bio Itera Life Science XpandInnovation KU Leuven UGent V-Bio Ventures Janssen

ABOUT BIOVOX - Sharing Life Sciences Innovations

BioVox showcases interesting life sciences breakthroughs for and from Belgian innovators. Through our partnership with BioCentury we share relevant worldwide innovations and business updates while our local journalists focus on regional highlights. 

Interested to get involved? Get in touch! We are looking for content, writers and partners! Blogs are available for research institutes, companies and freelance experts.

You want to reach out to the biotechnology and life sciences community, targetting selected audiences? Discover our sponsor and publication opportunities as well as tailored packages!

Contact BioVox via news@biovox.be or by completing the contact form.